Skip to content

Kodiak Sciences Inc KOD Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
Vera Therapeutics logo
Vera TherapeuticsVERA
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
Arcus Biosciences logo
Arcus BiosciencesRCUS

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.32B+1,477%
Enterprise value$2.2B+2,798%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kodiak Sciences Inc's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kodiak Sciences Inc's software and technology licenses, net?
Kodiak Sciences Inc (KOD) reported software and technology licenses, net of $8.68M in Q1 2026.
How has Kodiak Sciences Inc's software and technology licenses, net changed year-over-year?
Kodiak Sciences Inc's software and technology licenses, net increased by 0.2% year-over-year, from $8.66M to $8.68M.
What is the long-term trend for Kodiak Sciences Inc's software and technology licenses, net?
Over 5 years (2020 to 2025), Kodiak Sciences Inc's software and technology licenses, net has grown at a -3.2% compound annual growth rate (CAGR), from $10.21M to $8.67M.